435 related articles for article (PubMed ID: 30890933)
1. Curcumin Nanoformulations for Colorectal Cancer: A Review.
Wong KE; Ngai SC; Chan KG; Lee LH; Goh BH; Chuah LH
Front Pharmacol; 2019; 10():152. PubMed ID: 30890933
[TBL] [Abstract][Full Text] [Related]
2. Curcumin in the treatment of liver cancer: From mechanisms of action to nanoformulations.
Shelash Al-Hawary SI; Abdalkareem Jasim S; M Kadhim M; Jaafar Saadoon S; Ahmad I; Romero Parra RM; Hasan Hammoodi S; Abulkassim R; M Hameed N; K Alkhafaje W; Mustafa YF; Javed Ansari M
Phytother Res; 2023 Apr; 37(4):1624-1639. PubMed ID: 36883769
[TBL] [Abstract][Full Text] [Related]
3. Nanoformulations of quercetin for controlled delivery: a review of preclinical anticancer studies.
Joshi H; Gupta DS; Kaur G; Singh T; Ramniwas S; Sak K; Aggarwal D; Chhabra RS; Gupta M; Saini AK; Tuli HS
Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3443-3458. PubMed ID: 37490121
[TBL] [Abstract][Full Text] [Related]
4. Curcumin nanoformulations: Beneficial nanomedicine against cancer.
Maleki Dizaj S; Alipour M; Dalir Abdolahinia E; Ahmadian E; Eftekhari A; Forouhandeh H; Rahbar Saadat Y; Sharifi S; Zununi Vahed S
Phytother Res; 2022 Mar; 36(3):1156-1181. PubMed ID: 35129230
[TBL] [Abstract][Full Text] [Related]
5. Prospects of Curcumin Nanoformulations in Cancer Management.
Amekyeh H; Alkhader E; Sabra R; Billa N
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056675
[TBL] [Abstract][Full Text] [Related]
6. Potential Role of Curcumin and Its Nanoformulations to Treat Various Types of Cancers.
Kabir MT; Rahman MH; Akter R; Behl T; Kaushik D; Mittal V; Pandey P; Akhtar MF; Saleem A; Albadrani GM; Kamel M; Khalifa SAM; El-Seedi HR; Abdel-Daim MM
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33800000
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional polymeric nanocurcumin for cancer therapy.
Shehzad A; Ul-Islam M; Wahid F; Lee YS
J Nanosci Nanotechnol; 2014 Jan; 14(1):803-14. PubMed ID: 24730299
[TBL] [Abstract][Full Text] [Related]
8. Enhancing Curcumin Oral Bioavailability Through Nanoformulations.
Ipar VS; Dsouza A; Devarajan PV
Eur J Drug Metab Pharmacokinet; 2019 Aug; 44(4):459-480. PubMed ID: 30771095
[TBL] [Abstract][Full Text] [Related]
9. Curcumin nanoformulations: a future nanomedicine for cancer.
Yallapu MM; Jaggi M; Chauhan SC
Drug Discov Today; 2012 Jan; 17(1-2):71-80. PubMed ID: 21959306
[TBL] [Abstract][Full Text] [Related]
10. Nanocurcumin: A Double-Edged Sword for Microcancers.
Janjua KA; Shehzad A; Shahzad R; Islam SU; Islam MU
Curr Pharm Des; 2020; 26(45):5783-5792. PubMed ID: 33213321
[TBL] [Abstract][Full Text] [Related]
11. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.
Naksuriya O; Okonogi S; Schiffelers RM; Hennink WE
Biomaterials; 2014 Mar; 35(10):3365-83. PubMed ID: 24439402
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of curcumin and its nanoformulations for treating oral cancer.
Mukherjee D; Krishnan A
World J Methodol; 2023 Jun; 13(3):29-45. PubMed ID: 37456978
[TBL] [Abstract][Full Text] [Related]
13. Curcumin Based Drug Delivery Systems for Cancer Therapy.
Tiwari A; Jain SK
Curr Pharm Des; 2020; 26(42):5430-5440. PubMed ID: 32348207
[TBL] [Abstract][Full Text] [Related]
14. Cellular uptake and anticancer effects of mucoadhesive curcumin-containing chitosan nanoparticles.
Chuah LH; Roberts CJ; Billa N; Abdullah S; Rosli R
Colloids Surf B Biointerfaces; 2014 Apr; 116():228-36. PubMed ID: 24486834
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnology and curcumin: a novel and promising approach in digestive cancer therapy.
Zhang Y; Li Z; Huang Y; Xu Y; Zou B
Nanomedicine (Lond); 2023 Nov; 18(27):2081-2099. PubMed ID: 38078442
[TBL] [Abstract][Full Text] [Related]
16. Nano-based formulations of curcumin: elucidating the potential benefits and future prospects in skin cancer.
Ratan C; Arian AM; Rajendran R; Jayakumar R; Masson M; Mangalathillam S
Biomed Mater; 2023 Aug; 18(5):. PubMed ID: 37582394
[TBL] [Abstract][Full Text] [Related]
17. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines.
Doktorovova S; Souto EB; Silva AM
Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Applications of Curcumin Nanoformulations.
Yallapu MM; Nagesh PK; Jaggi M; Chauhan SC
AAPS J; 2015 Nov; 17(6):1341-56. PubMed ID: 26335307
[TBL] [Abstract][Full Text] [Related]
19. Curcumin, its derivatives, and their nanoformulations: Revolutionizing cancer treatment.
Ahmad I; Ahmad S; Ahmad A; Zughaibi TA; Alhosin M; Tabrez S
Cell Biochem Funct; 2024 Jan; 42(1):e3911. PubMed ID: 38269517
[TBL] [Abstract][Full Text] [Related]
20. Recent progress in studying curcumin and its nano-preparations for cancer therapy.
Liu J; Chen S; Lv L; Song L; Guo S; Huang S
Curr Pharm Des; 2013; 19(11):1974-93. PubMed ID: 23116308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
